ND4BB: Addressing the antimicrobial resistance crisis

Nature Reviews Microbiology

Volumn 12, Issue 4, 2014, Pages 231-232

  Rex, John H ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; NEW DRUG;

ANTIBIOTIC RESISTANCE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DIAGNOSTIC PROCEDURE; DRUG DESIGN PROGRAM; DRUG INDUSTRY; DRUG RESEARCH; GRAM NEGATIVE BACTERIUM; INFECTION PREVENTION; NOTE; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP;

EID: 84896402755     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro3245     Document Type: Note

References (5)

1. Boucher H. W. et al. Clin. Infect. Dis. 56, 1685-1694 (2013).
2. Morel C. M. & Mossialos E. BMJ 340, c2115 (2010).
3. Laxminarayan R. et al. Lancet Infect. Dis. 13,1057-1098 (2013).
4. Rex J. H. et al. Lancet Infect. Dis. 13, 269-275 (2013).
5. Caliendo A. M. et al. Clin. Infect. Dis. 57, S139-S170 (2013).